CHRS:NASDAQ
Coherus Oncology Inc
$1.45
arrow_downward
-7.94%(-0.12) 1D
$1.41
arrow_downward
-2.76% (-0.040)bedtimeAfter hours
Closed: Jun 5, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CHRS...
Open
$1.57
High
$1.57
Low
$1.44
Mkt. cap
222.95M
Avg. vol.
1.25M
Volume
908.73K
P/E ratio
0.87
52-wk high
$2.62
52-wk low
$0.71
EPS
$1.67
Beta
0.96
Shares outstanding
154.25M
No. of employees
145
Open
$1.57
High
$1.57
Low
$1.44
Mkt. cap
222.95M
Avg. vol.
1.25M
Volume
908.73K
P/E ratio
0.87
52-wk high
$2.62
52-wk low
$0.71
EPS
$1.67
Beta
0.96
Shares outstanding
154.25M
No. of employees
145
Analyst outlook
Analyst Ratings
Based on 5 analysts giving stock ratings to CHRS in the past 3 months
Strong Buy
Buy
5
Hold
0
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for CHRS in the last 3 months.
Highest
Current $1.45
$12.00 (+727.59%)
Average
$8.25 (+468.97%)
Lowest
$4.00 (+175.86%)
News stories
From sources across the web
Simply Wall Street
·
53 minutes ago
Fluence Energy Board Reshuffle Deepens AES Influence On Growth Priorities
MarketBeat
·
13 minutes ago
Pinebridge Investments LLC Invests $19.51 Million in Nasdaq, Inc. $NDAQ
Seeking Alpha
·
1 hour ago
S&P 500: This Is Not A Dip Yet (Rating Downgrade) (SPX)
About Coherus Oncology Inc
CEODennis Lanfear
Employees145
Founded2010
HeadquartersRedwood City, California, United States
SectorBiotechnology
Websitecoherus.com
AI content may include mistakes. Learn more